We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Baillie Gifford US Growth Trust plc (USA) Ordinary Shares

Sell:187.00p Buy:187.60p 0 Change: 0.20p (0.11%)
FTSE 250:0.27%
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:187.00p
Buy:187.60p
Change: 0.20p (0.11%)
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:187.00p
Buy:187.60p
Change: 0.20p (0.11%)
Market closed Prices as at close on 26 February 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To invest predominantly in listed and private US companies which the Company believes have the potential to grow substantially faster than the average company, and to hold onto them for long periods of time, in order to produce long term capital growth.
Security Weight
Shopify Inc Registered Shs -A- Subord Vtg 5.73%
Amazon.com Inc 4.69%
The Trade Desk Inc Class A 4.68%
NVIDIA Corp 4.47%
Tesla Inc 3.66%
Space Exploration Technologies Corp Series J Pref. 3.47%
Netflix Inc 2.71%
Workday Inc Class A 2.48%
DoorDash Inc Ordinary Shares - Class A 2.44%
Moderna Inc 2.30%
Sector Weight
Technology 29.67%
Communication Services 12.23%
Consumer Cyclical 12.17%
Healthcare 9.84%
Real Estate 1.83%
Industrials 1.46%
Consumer Defensive 1.20%
Financial Services 0.30%
Country Weight
United States 67.35%
Israel 1.36%

Fee Structure

The annual management fee is 0.70% on the first GBP 100m of net assets, 0.55% on the next GBP 900m of net assets and 0.50% for net assets in excess of GBP 1bn. The fee will be calculated and paid on a quarterly basis.. Agreement terminable on notice period of six months.

Dividend Policy

The Company’s priority is to produce capital growth over the long term. The Company therefore has no dividend target and will not seek to provide shareholders with a particular level of distribution.

ASSET SPLIT

Total number of holdings: 103.

Trust Manager

Gary Robinson

Manager Bio

Gary has been a member of the Global Stewardship Portfolio Construction Group since its inception in 2015 and is an Investment Manager in the US Equities Team. He graduated MBiochem in Biochemistry from the University of Oxford in 2003 and joined Baillie Gifford the same year. He spent time working on our Japanese, UK and European Equity Teams before moving to the US Equities Team in 2008. Gary is a generalist investor but retains a special interest in the healthcare sector dating back to his undergraduate degree. Gary became a Partner of the firm in 2019.

Board Of Directors

Thomas BurnetChairman, Graham Paterson, Susan Inglis, Christiaan van der Kuyl, Rachael Palmer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.